Jushi Holdings (JUSHF) Retained Earnings (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Retained Earnings came in at $512.3 million in Q1 2026, up 0.55% year-on-year from $509.5 million in Q1 2025, and little changed on a QoQ basis from $511.9 million in Q4 2025.
Jushi Holdings (JUSHF) Retained Earnings (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Retained Earnings data on file, last reported at $512.3 million in Q1 2026.
- On a quarterly basis, Retained Earnings rose 0.55% year-over-year to $512.3 million in Q1 2026; TTM through Mar 2026 was $512.3 million, a 0.55% increase from a year earlier, with the FY2025 full-year figure at $511.9 million, up 191.63% from the prior year.
- Retained Earnings for Q1 2026 stood at $512.3 million, roughly flat from $511.9 million in the prior quarter.
- Over the last five years, Retained Earnings for JUSHF reached as high as $512.3 million in Q1 2026 and fell as low as -$611.7 million in Q3 2025.
- Historically, Retained Earnings has averaged $82.6 million across 5 years, with a median of $497.2 million in 2023.
- Across the five-year window, Retained Earnings soared 299.95% in 2023 and tumbled 220.53% in 2025, its largest moves.
- Year by year, Retained Earnings stood at -$444.7 million in 2022, then surged by 213.24% to $503.6 million in 2023, then plunged by 210.92% to -$558.6 million in 2024, then soared by 191.63% to $511.9 million in 2025, then rose by 0.08% to $512.3 million in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were $512.3 million in Q1 2026, $511.9 million in Q4 2025, and -$611.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | 512.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 512.26 Mn |
| Dec 31, 2025 | 511.87 Mn |
| Sep 30, 2025 | -611.66 Mn |
| Jun 30, 2025 | 509.83 Mn |
| Mar 31, 2025 | 509.46 Mn |
| Dec 31, 2024 | -558.62 Mn |
| Sep 30, 2024 | 507.47 Mn |
| Jun 30, 2024 | -530.14 Mn |
| Mar 31, 2024 | -528.20 Mn |
| Dec 31, 2023 | 503.61 Mn |
| Sep 30, 2023 | 501.06 Mn |
| Jun 30, 2023 | 500.09 Mn |
| Mar 31, 2023 | 494.33 Mn |
| Dec 31, 2022 | -444.74 Mn |
| Sep 30, 2022 | -304.81 Mn |
| Jun 30, 2022 | -250.11 Mn |
| Dec 31, 2021 | -242.42 Mn |